Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting.

Autor:	Pacheco Silva, André, Scholz, Jaqueline, Abe, Tania Ogawa, Pinheiro, Gabriela Gouveia, Gaya, Patricia Viviane, Costa Pereira, Alexandre, Caleb Junior Lima Santos, Paulo, Silva, André Pacheco, Pereira, Alexandre Costa, Santos, Paulo Caleb Junior Lima
Předmět:	SMOKING cessation products BLOOD pressure HEART beat CARDIOVASCULAR diseases PATIENTS NICOTINE replacement therapy BUPROPION VARENICLINE HYPERTENSION CARDIOVASCULAR disease treatment CORONARY heart disease treatment TREATMENT of diabetes THERAPEUTICS THERAPEUTIC use of nicotine HYPERTENSION epidemiology CORONARY disease DIABETES DIASTOLE (Cardiac cycle) CARDIAC contraction DOPAMINE uptake inhibitors NICOTINE SMOKING SMOKING cessation COMORBIDITY NICOTINIC agonists EQUIPMENT & supplies
Zdroj:	BMC Cardiovascular Disorders; 1/5/2016, Vol. 16, p1-6, 6p, 2 Charts
Abstrakt:	Background: Smoking is the most important reversible cardiovascular risk factor. It is well established that quitting smoking reduces coronary events. However, on several occasions, the cardiovascular safety of smoking cessation drugs has been questioned. Our goal is to evaluate the effects of smoking cessation drugs on blood pressure and heart rate in patients from a smoking cessation service in a cardiology hospital.Methods: We examined the PAF database (Smoking Cessation Assistance Program database) between January 2008 and March 2014. We analyzed data from 900 patients who were compliant with the treatment (50.5% male, average age 53 ± 17 years). The most frequent clinical diagnoses were coronary artery disease (25.2%), hypertension (57.2%), and diabetes (13.4%). Blood pressure, heart rate, and carbon monoxide (CO) concentration in exhaled air were analyzed at consecutive visits during the first 45 days of treatment (mean visits - 3). Analysis of repeated measures was used for the statistical analysis (p < 0.05).Results: Two hundred seventy one patients used nicotine replacement therapy (NRT) alone, 81 used bupropion alone, 154 used varenicline alone, 283 used NRT plus bupropion and 111 used bupropion plus varenicline. For all smoking cessation drugs, used alone or in combination, no increase occurred in the average value of systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR). Significant reductions in CO concentrations occurred in all smoking cessation drug groups.Conclusion: Smoking cessation drugs used in monotherapy or in combined regimens did not influence systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) in this group of patients during the observation period. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink